Surveillance of Emerging Pathogens to Ensure Blood Supply Safety

Stopped The kits were FDA and Health Canada approved and therefore the clinical trial is no longer needed.

Conditions

• Babesioses, Human

Interventions

• DIAGNOSTIC_TEST: Babesia NAT

Sponsor

Canadian Blood Services